z-logo
open-access-imgOpen Access
A perspective on diuretic resistance in chronic congestive heart failure
Author(s) -
Niel Shah,
Raef Madanieh,
Mehmet Alkan,
Muhammad Dogar,
Constantine E. Kosmas,
Timothy J. Vittorio
Publication year - 2017
Publication title -
therapeutic advances in cardiovascular disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 33
eISSN - 1753-9455
pISSN - 1753-9447
DOI - 10.1177/1753944717718717
Subject(s) - diuretic , heart failure , medicine , loop diuretic , pharmacodynamics , cardiology , pharmacology , intensive care medicine , pharmacokinetics
Chronic congestive heart failure (CHF) is a complex disorder characterized by inability of the heart to keep up the demands on it, followed by the progressive pump failure and fluid accumulation. Although the loop diuretics are widely used in heart failure (HF) patients, both pharmacodynamic and pharmacokinetic alterations are thought to be responsible for diuretic resistance in these patients. Strategies to overcome diuretic resistance include sodium intake restriction, changes in diuretic dose and route of administration and sequential nephron diuretic therapy. In this review, we discuss the definition, prevalence, mechanism of development and management strategies of diuretic resistance in HF patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom